What do we already know about this topic?

• Understanding the patient’s path to taking recommended preventative migraine medication may help identify barriers to effective treatment.
• Previous studies have not considered episodic and chronic migraine together and took place in a historical healthcare environment.^3,4
• The observational survey of the epidemiology, treatment and care of migraine (OVERCOME) was a web-based survey providing a contemporary view of the migraine healthcare landscape, considering both episodic and chronic migraine.

How was this study conducted?

• Subgroup analysis of adult patients from the OVERCOME study with moderate or severe migraine-associated disability (n=5,873), validated by AMS/AMPP diagnostic screener or self-report healthcare provider (HCP) diagnosis.⁵
• Subgroups were based upon whether patients sought care over the past 12 months, migraine diagnosis by a HCP, and taking recommended preventative treatment, with data stratified by monthly headache days category: 4–7, 8–14, ≥15 days.
• Considered measurements of migraine disability, cutaneous allodynia, symptom severity, treatment optimization, quality of life related to migraine, and pain severity. ^6,7,8,9